Abstract:Introduction: Cervical cancer (CC) ranks as the fourth most prevalent malignant tumor among women worldwide, and is the fourth leading cause of cancer-related mortality. GuiErBai (GEB), a compound preparation developed by our research team, is derived from the ancient Chinese medicine of the Miao nationality and is comprised of podophyllotoxin (PTOX), imperatorin, isoimperatorin, and A. dahurica alkaloids. These individual components have demonstrated notable efficacy in tumor treatment. However, the specific anti-tumor effect of the compound Chinese medicine GEB in the context of CC has yet to be validated. Methods: HeLa and SiHa cell lines were utilized for in vitro experiments and treated with 5 mg/mL and 10 mg/mL GEB concentrations, respectively. The cell cycle changes after GEB treatment were assessed using flow cytometry. Transmission electron microscopy was employed to observe autophagic bodies and apoptotic bodies, while MDC staining evaluated the occurrence of autophagy. CCK-8 was used to observe the effect of GEB on cell proliferation, and Transwell assays assessed cell migration and invasion. Western blotting detected cell cycle and apoptosis-related protein expression, along with the expression level of autophagy-related protein LC3I/II. Changes in ROS and mitochondrial membrane potential in cervical cancer cells following GEB treatment were determined using ROS detection and mitochondrial membrane potential detection kits. For the in vivo experiment, a nude mouse model of cervical cancer transplantation based on HeLa cells was established. Experimental animals were divided into negative control, positive control, high-dose GEB (10 mg/mL), and low-dose GEB (5 mg/mL) groups. Results: In HeLa and SiHa cell lines, the G0/G1 phase of tumor cells significantly decreased ( p < 0.001), while the G2/M phase increased notably ( p < 0.001) following various GEB treatments. Electron microscopy showed GEB promoted apoptotic body and autophagosome formation in both cell lines. Compared to untreated HeLa and SiHa cells, GEB-treated cells exhibited significantly reduced caspase3 protein expression, and substantially increased autophagy-related protein LC3I/II expression. GEB treatment significantly reduced migration and invasion capabilities in both cell lines ( p < 0.001), while ROS content and mitochondrial membrane potential were significantly elevated ( p < 0.001). GEB effectively inhibited cervical cancer cell proliferation, with the optimal concentration being 10 mg/mL. A successful nude mouse model of cervical cancer transplantation was established using HeLa cells. Post-GEB treatment, the tumor volume and weight in nude mice significantly decreased ( p < 0.001), with diminished expression of CD34, VEGF, and caspase3 proteins in tumor tissues. Discussion: GEB exhibits a robust antitumor effect against cervical cancer, both in vitro and in vivo , in a concentration-dependent manner, by regulating autophagy and apoptosis of tumor cells.

Inhibitory effect of resibufogenin on transphantation tumor growth of human cervical cancer Hela cells in rude mice

Apoptosis of Implanted Tumor of Human Primary Gastric Cancer Cells in Nude Mice Induced by Resveratrol

Interventional effect of resibufogenin on the cell growth of human gastric cancer BGC-823 cell line

In vitro and in vivo study of BZG-4000: Anti-tumoral activity of human hepatocellular carcinoma

Resibufogenin Suppresses Triple-Negative Breast Cancer Angiogenesis by Blocking VEGFR2-Mediated Signaling Pathway

Anti-angiogenic Effect of Ginsenoside Rg3 in Nude Mice Cervical Cancer

Influence of Traditional Chinese Compound Recipes with Different Efficacy on Body Weight, Tumor Weight and Immune Function in H22 Cancer-Bearing Mice

[Antiangiogenesis of Ginsenoside Rg3 in Severe Combined Immunodeficient Mice with Human Ovarian Carcinoma].

[Effect of Cinobufotalin on Growth of Xenograft of Endometrial Carcinoma Cell Line Ishikawa in Nude Mouse and Its Impact on RRM2 Expression].

GuiErBai: a potent inhibitor, exhibiting broadly antitumor effect against cervical cancer in vitro and in vivo

Study on the Effect of Ginsenosides Rb on Blood of Tumor Mice

Ginsenoside Rg3 Inhibits CXCR4 Expression and Related Migrations in a Breast Cancer Cell Line.

Liver-targeting Resibufogenin-loaded poly(lactic-co-glycolic acid)-D-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy

Anti-angiogenic Effects of Cisplatin Combined with Ginsenoside Rg3 in Nude Mice Cervical Cancer

[Effects of Compound Zhebei Granule plus doxorubicin on mdr 1 gene expression in nude mice with K562/A02 tumor xenografts]

Inhibit effect of Chinese herbal compound "Zhenmingzhengsheng" on three models of nude mice xenograft with human tumor cells

Inhibitory Effects of Chanling Gao on the Proliferation and Liver Metastasis of Transplanted Colorectal Cancer in Nude Mice

The Study of Resibufogenin on Induction of the Apoptosis of Human Hepatocarcinoma Bel-7402 Cells by the Mitochondrial-dependent Pathway

Inhibitory Effect of Huaier on Recurrent Tumor Growth Following Hepatic Resection of Hepatocellular Carcinoma

Evaluation of Inhibition Activity of VCR Transfersomes on Burkitt's Lymphoma in Nude Mice

The preventive role of the red gingeng ginsenoside Rg3 in the treatment of lung tumorigenesis induced by benzo(a)pyrene